Medicine and Dentistry
ST Segment Elevation Myocardial Infarction
100%
Major Adverse Cardiac Event
73%
Acute Coronary Syndrome
71%
COVID-19
47%
Chronic Kidney Disease
45%
Symptom
35%
Retrospective Cohort Study
31%
Infection
30%
Autoimmune Disease
27%
Primary Percutaneous Coronary Intervention
25%
Fibroblast Growth Factor 23
20%
Neutrophil
18%
Cardiovascular Disease
16%
Killip Class
15%
Door-to-Balloon
15%
Cross Sectional Study
15%
Cohort Analysis
15%
Lymphocyte
15%
Coronary Artery
14%
Health Care
13%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Atrial Myxoma
13%
Heart Rate Variability
13%
Depression
13%
Dressler's Syndrome
13%
Heart Valve
13%
Vitamin D
13%
Serotonin
13%
Somatics
13%
ST Elevation
13%
Endocarditis
13%
Hydrocortisone
13%
Post-COVID-19
13%
Coronary Artery Disease
13%
Artery Lesion
13%
QRS Complex
13%
Gensini Score
13%
Bivariate Analysis
10%
Heart Tumor
10%
Heart Left Ventricle Ejection Fraction
10%
Percutaneous Intervention
9%
Mortality Rate
8%
Medical Record
7%
Logistic Regression Analysis
7%
Percutaneous Coronary Intervention
7%
Glomerulus Filtration
6%
Thorax Pain
6%
Steroid Treatment
6%
Midazolam
6%
Systemic Lupus Erythematosus
6%
Keyphrases
ST-elevation Myocardial Infarction (STEMI)
96%
Adverse Cardiac Events
60%
Myocardial Infarction Patients
49%
Acute Coronary Syndrome
44%
Chronic Kidney Disease
27%
Pada
20%
Fibroblast Growth Factor 23 (FGF23)
20%
Clinical Outcomes
19%
Door-to-balloon Time
17%
Retrospective Cohort Study
16%
COVID-19 Pandemic
15%
Indonesia
15%
Marketing Strategy
15%
Program Implementation
14%
NaFeEDTA
13%
Iron Absorption
13%
Autoimmune Disease
13%
Booster Vaccination
13%
Iron Deficient
13%
Primary Cardiac Tumors
13%
Non-heme Iron
13%
Healthcare Workers
13%
Indonesian
13%
Dressler Syndrome
13%
Persistent ST-segment Elevation
13%
Fe(II)
13%
Libman-Sacks Endocarditis
13%
Lead aVR
13%
Valvular Involvement
13%
Quality Assurance
13%
MRNA-1273
13%
β2-microglobulin (β2-MG)
13%
SARS-CoV-2 Infection
13%
30-day Mortality
13%
Vitamin D
13%
Post-acute Coronary Syndrome
13%
Randomized Clinical Trial
13%
Coronary Stenosis Severity
13%
Simulation Case
13%
Percutaneous Intervention
13%
Breakfast
13%
Quality of Health Care
13%
Anxiety Symptoms
13%
SAECG
13%
Marketing Analysis
13%
Depressive Symptoms
13%
Systematic Literature Review
13%
Fragmented QRS Complex
13%
FeSO4
9%
Bivariate Analysis
8%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
70%
Major Adverse Cardiac Event
55%
Chronic Kidney Failure
45%
ST Segment Elevation Myocardial Infarction
34%
Cohort Study
32%
Coronavirinae
27%
Symptom
26%
Midazolam
20%
Cross-Sectional Study
20%
Thorax Pain
18%
Observational Study
17%
Disease
15%
Depression
13%
Vaccination Policy
13%
Cardiovascular Disease
13%
Rankin Scale
13%
Transferrin
13%
Ferrous Ion
13%
SARS Coronavirus
13%
Dressler's Syndrome
13%
Heart Arrhythmia
13%
Infection
13%
Biological Marker
13%
Tachycardia
13%
Serotonin
13%
Virus Infection
13%
Artery Lesion
13%
Ethylenediaminetetraacetic Acid
13%
Randomized Clinical Trial
13%
Fibroblast Growth Factor 23
13%
Acute Heart Infarction
13%
Brain Natriuretic Peptide
13%
Hydrocortisone
13%
Heart Infarction
9%
Prevalence
9%
Hypomagnesemia
9%
Troponin
7%
Dyspnea
6%
Cardiogenic Shock
6%
Pericarditis
6%
Agar
6%
Amitrole
6%
Diabetes Mellitus
6%
Fenofibrate
6%
Heart Left Ventricle Hypertrophy
5%
